Hjem › Hjertesvikt › Louisiana
Kliniske studier for Hjertesvikt i Louisiana
18 studier for Hjertesvikt søker deltakere på steder i Louisiana.
Byer i Louisiana
- New Orleans7 studier
- Houma7 studier
- Hammond5 studier
- Baton Rouge5 studier
- Monroe5 studier
- Shreveport4 studier
- Lafayette3 studier
Offisiell studietekst (engelsk)
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, West Monroe
RekruttererFase 3
Alder 18 til 130 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Heart Clinic of Hammond, Hammond
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Grace Research, LLC-Bossier City-51040, Bossier City
- Heart Clinic of Hammond, Hammond
- Grace Research, LLC-Shreveport-64616, Shreveport
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06424288A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Cardiovascular Institute of the South, Houma
Rekrutterer
Alder 18 til 85 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07214376A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Bossier City
- Research Site, Covington
- Research Site, Lafayette
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- University Medical Center New Orleans, New Orleans
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06736574Alleviant ALLAY-HFrEF Study
- Cardiovascular Institute of the South, Houma
- University Medical Center New Orleans, New Orleans
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT06812533Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Our Lady of the Lake Medical Center, Baton Rouge
- Louisiana Heart Center - Hammond, Covington
- Heart Clinic of Hammond, Hammond
- og 1 flere
RekruttererFase 3
Alder 18 til 99 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Alexandria
- Research Site, Bossier City
- Research Site, Shreveport
RekruttererFase 3
Alder 40 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10030 Baton Rouge, LA Investigational Site, Baton Rouge
- CON-10090, West Monroe, LA, West Monroe
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Baton Rouge, LA Investigative Site 10030, Baton Rouge
- Hammond, LA Investigative Site 10106, Hammond
- West Monroe, LA Investigative Site 10090, West Monroe
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06008197A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 155, Houma
RekruttererFase 2
Alder 30 til 84 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07795814LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, New Orleans
- Tenax Investigational Site, West Monroe
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 19. aug. 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Grace Research, LLC, Bossier City
- Horizon Research Group of Opelousas, LLC, Eunice
- Cardiovascular Institute of the South, Houma
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07567001Alleviant ALLAY-HF Study
- Cardiovascular Institute of the South, Houma
- University Medical Center New Orleans, New Orleans
Rekrutterer
Alder 40 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT05685303A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10030, Baton Rouge, LA, Baton Rouge
- FIN-10106, Hammond, LA, Hammond
- FIN-10090, West Monroe, LA, West Monroe
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jul. 2026 · NCT06033950The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Cardiovascular Institute South, Houma
- Ochsner Health System, New Orleans
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 13. apr. 2026 · NCT03142152AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
- Cardiovascular Institute of the South, Houma
- Cardiovascular Institute of the South, Lafayette
- University Medical Center New Orleans, New Orleans
RekruttererObservasjonsstudie
Alder 22 og eldre · Alle kjønn · Oppdatert 26. mar. 2025 · NCT06378632Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.